Home Equities Score Why Cyclerion Therapeutics, Inc. (CYCN) stock is falling today?

Why Cyclerion Therapeutics, Inc. (CYCN) stock is falling today?

Shares of Cyclerion Therapeutics, Inc. (CYCN) were continued to fall in the pre-market trading session today on April 28, 2021, after recording the drop of 17.95% at the previous closing. CYCN stock price was down by 2.34% today to drop at $2.50 a share at the time of this writing. The pipeline progress discussed by Cyclerion Therapeutics is the most recent news that appeared on April 27, 2021. Let’s see the current happenings.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s happening?

Cyclerion Therapeutics, Inc is a clinical-stage biopharmaceutical company founded in 2018 and working on the discovery, development, and commercialization of medicines for the treatment of patients suffering from serious central nervous system disorders.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

CYCN hosted the webinar on April 27, 2021, in order to discuss its pipeline progress.CYCN provided updates regarding its first-in-class, CNS-penetrant soluble guanylate cyclase (sGC) stimulator CY6463 in Alzheimer’s Disease. The potential for CY6463 in order to treat Cognitive impairment Associated with Schizophrenia was also discussed in the webinar by the CYCN stock based on its recent clinical and preclinical data. Furthermore, CYCN introduced its new development candidate CY3018 which is a differentiated next-generation CNS-penetrant sGC stimulator.

On April 26, 2021, Cyclerion appointed Errol De Souza, Ph.D. to its board of directors. Dr. De Souza is an experienced seasoned R&D and business leader. He served many large biopharmaceutical companies as well as startups in the discovery and development of medicines for the treatment of central nervous system disorders. Dr. De Souza is an active member of the board of directors of Royalty Pharma and Catalyst Biosciences and executive chairman of Bionomics Limited.

Financial View of CYCN stock:

As of March 31, 2021, Cyclerion Limited had cash, cash equivalents, and a restricted cash balance of $45 million while these were totaled  $58 million on December 31, 2020.CYCN stock is focused on investing more in opportunities related to cognition and expects the monthly cash use to be 50% percent that of 2020.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

CYCN stock is gloomy as far as market sentiment is concerned and no one knows how long this downtrend will continue. From investment perspective, it is better to research deeply about Cyclerion’s fundamentals, balance sheet, future growth, and recent financial results before adding this stock to the portfolio.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Fastly, Inc. (NYSE: FSLY) stock plunged in the pre-market trading session: here’s why

Fastly, Inc. (NYSE: FSLY), a company specializing to provide real-time content delivery network services, which offers edge cloud platform, edge software development kit (SDK),...

What Is The Reason For GreenBox (GBOX) Stock Rallying In Pre-Market?

In premarket trading hours, GreenBox POS (NASDAQ: GBOX) rose 5.34% to $11.24 on the last check Thursday. GreenBox stock gained 1.81% to close at...

Why Is The HOME Stock Getting Raised In Pre-Hour Trades?

At last check, shares of At Home Group Inc. (NYSE: HOME) were up 14.90 percent to trade at $36.01 in premarket session today. The...

What Caused Nemaura (NMRD) To Rise Today In Premarket Session?

The shares of Nemaura Medical Inc. (NASDAQ: NMRD) were trading 12.12% higher at $12.4 before the bell at last check. Nemaura stock closed the...

Luokung Technology Corp. (LKCO) Stock Surges Amid China-U.S. Economic Tensions

Luokung Technology Corp. (LKCO) stock prices were down by 8.64% as of the market closing on May 5th, 2021, bringing the price per share...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.